Extracellular ubiquitin inhibits the apoptosis of hepatoma cells via the involvement of macrophages.

BACKGROUND: Blood transfusion is a vital treatment for cancer patients, but some studies have proved that there is an association between transfusion and the risk of cancer recurrence. Storage time influences the quality of red blood cells (RBCs), and the transfusion of aged RBCs can result in hepatocellular carcinoma (HCC) recurrence, which could be related to the ubiquitin (Ub) released by aged RBCs. In this study, we explored the effect of eUb on the biological characteristics of hepatoma cells.
METHODS: We checked the proliferation and apoptosis of hepatoma cells (MHCC-97H and HepG2.2.15) by CCK-8, colony formation assay, flow cytometry and Western blot. THP-1-derived macrophages were used in this study, and the co-culturing of hepatoma cells with macrophages was initiated with Transwell inserts. We also measured the secretion of macrophages through ELISA.
RESULTS: eUb did not directly influence the proliferation and apoptosis of hepatoma cells. However, the Akt/mTOR signaling pathway in hepatoma cells was activated, and the apoptosis of hepatoma cells was inhibited significantly after they were co-cultured with the macrophages pretreated with eUb. In addition, we confirmed that eUb modulated the phenotype and secretion function of macrophages.
CONCLUSIONS: Extracellular Ub repressed the apoptosis of hepatoma cells via the involvement of macrophages, which might affect the local tumor microenvironment and display pro-tumor effect. 2020 Translational Cancer Research. All rights reserved.

Introduction

Blood transfusion is a necessary treatment for cancer patients. Among multiple malignant cancers, the pathological characteristics of hepatocellular carcinoma (HCC), such as suppressed hematopoietic function, chronic blood loss, and intraoperative bleeding, blood transfusion is a vital treatment for HCC patients. However, several clinical and laboratory studies have confirmed the relationship between transfusion and the increased risk of recurrence and mortality in HCC (1-3). Storage time has been confirmed to influence the quality of red blood cells (RBCs), and the aging of RBCs in the storage bag (storage lesion) results in detrimental clinical outcomes, such as acute kidney/lung injury, pneumonia, infection, and cancer recurrence (4,5). Various biological molecules in stored RBCs are involved in transfusion-related immunomodulation (6) and may affect the recurrence and prognosis of HCC patients after the transfusion of aged RBCs.

Ubiquitin (Ub) is a highly conserved heat-stable 8.5 kDa protein in all eukaryotic cells, and the source of Ub may be the passive release from the necrotic and apoptotic cells (7). Lots of diseases can lead to increased Ub concentration in body fluids, such as type 2 diabetes, parasitic and allergic diseases, alcoholic liver disease, chronic hemodialysis, and traumatic injury (8). In addition, Ub can be released by normal cells (9,10). The concentration of Ub in RBC is 10–20 ng/106 cells and that is 1,000–10,000-fold higher than other blood cells. Ub in RBC units increased 20-fold on day 42 than day 0 due to the hemolysis occurred with the prolonged RBC storage (11,12). The most important effect of intracellular Ub is mediating protein degradation by the Ub-proteasome system. The protein degradation mediated by Ub exerts a vital influence on the regulation of multiple processes, such as protein trafficking, endocytosis, cell-cycle progression, transcriptional regulation, and signal transduction. The function of intracellular Ub is comparatively well studied, while less is known about the effect of extracellular ubiquitin (eUb) (13). In previous studies, eUb was shown to modulate the growth and apoptosis of hematopoietic cells (14), exert anti-inflammatory, and have an immunoregulation effect (15,16), which is supposedly related to the immunoregulatory properties of aged RBCs.

Due to the immunoregulation function of eUb and the development and progression of HCC depending on patients’ immunity, we speculated that the increased eUb during the storage of RBCs might play a vital role in the progression and recurrence of HCC after the transfusion of aged RBCs. However, there is a lack of research aimed at exploring the pro-tumor potential of eUb, so we intended to carry out an exploration into the impact eUb has on hepatoma cells and explore the potential mechanisms underlying HCC recurrence induced by the transfusion of aged RBCs, in the hope of alleviating the adverse outcomes of HCC patients after aged RBC transfusion treatment.

Methods

Cells and reagents

We purchased human hepatoma cell lines MHCC-97H and HepG2.2.15, human monocyte THP-1 cells from Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China). MHCC-97H and HepG2.2.15 were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (both Hyclone; GE Healthcare Life Sciences, Logan, UT, USA), penicillin (100 U/mL) and streptomycin (100 µg/mL; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). THP-1 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum and penicillin/streptomycin. The incubation of the cells took place in a humidified incubator under 5% CO2 at 37 °C. eUb and PMA were sourced from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). We purchased all antibodies, including mTOR (#2983), p-mTOR (#2971), Akt (#4691), p-Akt (#9271), Bcl-xl (#2764), Bax (#5023), and GAPDH (#2118) from Cell Signaling Technology (Beverly, MA, USA).

CCK8 assay

Cells were seeded in 96-well plates (2×103 per well) and left to incubate for a period of 24 h. Each well had eUb added in a concentration series, and incubation was carried out for 24, 48, and 72 h, respectively. Further addition of 10 µL CCK8 was made to each well, and further incubation took place for 4 h at 37 °C. Absorbance was detected by a multi-mode detection platform (Molecular Devices Austria GmbH, Wals, Austria) at 490 nm.

Colony-formation assay

Different amounts of cells were seeded in 6-well plates: 100 cells/well in 97H and 200 cells/well in HepG2.2.15, respectively. The incubation of hepatoma cells was carried out with eUb over a period of 2 weeks, with the culture medium changed every 3 days. Then, we aspirated off the culture medium and washed the wells 3 times with PBS before fixing the cells with 20% methanol for 15 min. We stained the cells with Giemsa for 20 min and calculated the colony number to compare cell proliferation.

Cell apoptosis analysis

Flow cytometry was used to detect cell apoptosis via Annexin V-FITC/PI staining (KeyGen Biotech, Jiangsu, China). Then, 1×106 cells were washed with PBS and resuspended in 100 µL binding buffer containing 5 µL PI and 5 µL Annexin V-FITC. Incubating these cells at room temperature in the dark for 15 min according to the manufacturer’s instructions. Lastly, analysis of the cells was performed by flow cytometry with a FACSCalibur flow cytometer (BD Biosciences, NY, USA). FlowJo software was used for data analysis.

Cell cycle analysis

Cells were fixed in 70% ethanol at 4 °C overnight, and then the cells were washed twice with PBS and stained with propidium iodide at a final concentration of 50 ng/mL at room temperature for 30 min. Finally, the stained cells were analyzed by flowcytometry.

Enzyme-linked immunosorbent assay (ELISA)

Commercial ELISA kits (R&D Systems, Minneapolis, MN, USA) were used to measure TNF-α and IL-10 concentrations. Culturing of the THP-1 cells was carried out using 6-well plates, pretreated with PMA for a period of 24 h, and then incubated with Ub (1–10 µg/mL) for 24, 48, and 72 h, respectively. Supernatants were collected and stored at −80 °C pending assay. ELISA assay was performed following the instructions of the manufacturer, and each of the samples was measured in triplicate. We calculated the TNF-α and IL-10 concentration via a standard curve.

Western blot

Ice-cold PBS was applied to wash the cells, and extracts were prepared with lysis buffer containing protease inhibitor. Lysates were subjected to SDS-PAGE and electrophoretically transferred to PVDF membranes. The membranes underwent blocking with 5% BSA at room temperature for 1 h and then underwent a period of incubation overnight with the primary antibody at 4 °C. The next day, the membranes were washed and incubated for 1 h with the second antibody conjugated to horseradish peroxidase at room temperature. The protein signal was detected by Fusion FX7 (VILBER, Paris, France).

Co-culturing of hepatoma cells with macrophages

1×106 THP-1 cells were seeded into polycarbonate membrane inserts (pore size, 0.4 µm; Corning, NY, USA) and pre-incubated with PMA to induce M0 macrophages. 24 h later, the M0 macrophages were treated with eUb (10 µg/mL) for 72 h. Meanwhile, 1×106 97H and HepG2.2.15 cells were seeded in a 6-well plate over a period of 24 h, and then the inserts were put into the 6-well plate to initiate co-culture. After 72 h of co-culturing, the 97H and HepG2.2.15 cells were collected for the following analysis.

Statistical methods

Statistical analysis was conducted out with GraphPad Prism. Data were expressed as mean ± SD. Data comparison was made with Student’s t-test as well as a one-way ANOVA test. P<0.05 was considered statistically significant.

Results

eUb had no significant effect on the proliferation and apoptosis of hepatoma cells

To understand the part of eUb released by the aged RBCs in the progression and recurrence of HCC, the influence of eUb in hepatoma cell (MHCC-97H and HepG2.2.15) proliferation and apoptosis was observed. 97H and HepG2.2.15 cells underwent treatment with different concentrations of eUb (1, 2, 5, 10 µg/mL) and were incubated over a period of 24, 48, and 72 h, respectively.

The CCK8 and cell cycle results showed that eUb did not affect the proliferation and cell cycle of 97H and HepG2.2.15 cells significantly (). The same result was obtained from the colony-formation assay (). In addition, the apoptosis of 97H and HepG2.2.15 cells after 72 h treatment with eUb (10 µg/mL) were detected by flow cytometry and the results showed that eUb did not alter the apoptosis of hepatoma cells (). Furthermore, we detected that key proteins were expressed in the Akt/mTOR signaling pathway which is influential in stimulating growth and proliferation in cells. Bcl-xl and Bax that were related to the cell apoptosis were also examined. The result showed that the total and phosphorylated protein levels of mTOR and Akt, Bcl-xl, and Bax were not changed simultaneously (). The above results demonstrated that eUb has no direct effect on hepatoma cell proliferation and apoptosis.

Figure 1

eUb had no significant effect on the proliferation and apoptosis of hepatoma cells. 97H and HepG2.2.15 cells were treated with eUb at different concentrations (1, 2, 5, 10 µg/mL) over a period of 24, 48, and 72 h, respectively. Cell proliferation was measured by CCK8 (A) and colony-formation assays (C). Following eUb treatment, cell cycle and apoptosis were detected by flowcytometry (B,D). The protein was collected to assess the expression of mTOR, p-mTOR, Akt, p-Akt, Bcl-xl, and Bax by Western blotting, with GAPDH serving as a loading control (E). Each experiment was performed independently three times. Results are expressed as means ± SD. CON. Control. *, P<0.05.

Hepatoma cell proliferation was not influenced after co-culturing with macrophages pretreated by eUb

Since eUb exerts anti-inflammatory and immunoregulatory effects, and macrophage is reported to affect the growth and proliferation of cancer cells, we speculated that eUb might affect the proliferation of hepatoma cells via the involvement of macrophages. As the differentiation of human THP-1 monocytes has been commonly used as a model of human macrophages in vitro, we seeded THP-1 cells on inserts to differentiate into M0 macrophages through incubation along with phorbol 12-myristate 13-acetate (PMA). After 24 h, the THP-1 cells were adherent and then were treated with eUb (1, 5, 10 µg/mL) for 72 h. Afterward, the same amount of 97H and HepG2.2.15 cells were co-cultured with Ub-pretreated macrophages via indirect contact by Transwell inserts which allowed the exchange of soluble factors.

After 72 h of co-culturing, 97H and HepG2.2.15 cells were collected to measure their proliferation by CCK8 and colony-formation assays. The results showed that the involvement of the eUb-treated macrophages did not influence the proliferation and cell cycle of 97H and HepG2.2.15 (). However, it’s worth noting that mTOR and Akt abundance were both increased after co-culturing with macrophages pretreated by eUb (). These findings suggested that the co-culturing with macrophages pretreated by eUb activated the Akt/mTOR signaling pathway in hepatoma cells, which might be related to cell growth and proliferation.

Figure 2

The proliferation of hepatoma cells was not influenced after cocultured with macrophages pretreated by eUb. THP-1 monocytes were preincubated by 100 nM PMA for 24 h to induce M0 macrophages and then treated with eUb. 97H and HepG2.2.15 cells were cocultured with macrophages (pretreated by 10 µg/mL eUb for 72 h) via Transwell inserts (pore size, 0.4 µm). After 72 h incubation, 97H and HepG2 cells were collected to measure the proliferation ability by CCK8 (A), flowcytometry (B), and colony-formation assays (C). The protein of 97H and HepG2.2.15 cells after cocultured with macrophages (pretreated by 1, 5, 10 µg/mL eUb for 72 h) were extracted to detect the expression of mTOR, p-mTOR, Akt, and p-Akt through Western blotting, with GAPDH serving as a loading control (D). *, P<0.05.

Hepatoma cell apoptosis was inhibited after co-culturing with macrophages pretreated by eUb

To further explore the pro-tumor effects of eUb on hepatoma cells via the involvement of macrophages, the apoptosis of 97H and HepG2.2.15 cells after co-culturing were detected. 97H and HepG2.2.15 cells were collected after being co-cultured with macrophages pretreated by eUb, and then flow cytometry and Western blotting were conducted to assess apoptosis in relation to hepatoma cells. The apoptosis of 97H and HepG2.2.15 cells were both decreased (), and Bcl-xl abundance was increased while no significant alteration of Bax abundance was observed in 97H and HepG2.2.15 cells after co-culturing with eUb-treated macrophages (). Collectively, we could draw a conclusion that eUb inhibited the apoptosis of hepatoma cells via the involvement of macrophages.

Figure 3

The apoptosis of hepatoma cells was inhibited after co-culturing with macrophages pretreated by eUb. THP-1 monocytes were pre-incubated by PMA to induce M0 macrophages and then treated with eUb. (A) After co-culturing with macrophages (pretreated by 10 µg/mL eUb for 72 h), 97H and HepG2.2.15 cells were collected to measure apoptosis by flow cytometry; (B) after being co-cultured with macrophages (pretreated by 1, 5, 10 µg/mL Ub for 72 h), the protein of 97H and HepG2.2.15 cells were extracted to detect the expression of Bcl-xl and Bax by Western blot. GAPDH was used as a loading control. *, P<0.05.

eUb modulated the phenotype and secretion function of macrophages

To explore the effect of eUb on macrophage specifically, we conducted a CCK8 assay to evaluate the influence of eUb on THP-1 monocyte proliferation, and we did not observe eUb to have a significant effect on monocyte growth (). However, we noticed the phenotype alteration of eUb-treated macrophages, which became elongated, flat and branching compared with the control group treated with PBS ().

Figure 4

eUb modulated the phenotype and secretion function of macrophages. (A) THP-1 monocytes were treated with eUb at different concentrations (1, 2, 5, 10 µg/mL) for a period of 24, 48 and 72 h, respectively. CCK8 assay was carried out to measure the proliferation of cells. THP-1 monocytes were preincubated by PMA to induce M0 macrophages and then treated with eUb; (B) images of M0 macrophages treated with eUb (10 µg/mL) and PBS for 72 h were captured under a microscope (magnification, ×200); (C) after treated with eUb (1, 2, 5, 10 µg/mL) for a period of 24, 48, and 72 h, respectively, TNF-α and IL-10 secretion in macrophage culture medium were measured through ELISA.

Tumor-associated macrophages (TAMs) are reported to modulate inflammatory and immune responses in the tumor microenvironment through cytokines secretion, such as pro-inflammatory cytokine TNF-α and anti-inflammatory cytokine IL-10. To examine the alteration of macrophage secretion upon eUb exposure, TNF-α and IL-10 in macrophage culture medium were measured by ELISA after eUb treatment. TNF-α was not detected after 24 h exposure while its concentration was up-regulated as the incubation time increased, and Ub inhibited TNF-α secretion compared with the control group. Meanwhile, IL-10 was increased with the incubation time, but Ub did not up-regulate IL-10 significantly (). Therefore, we speculated that eUb could modulate the phenotype and secretion function of macrophages.

Discussion

There is a few researches that has explored the biological effects of eUb in recent years, Singh et al. found eUb exerted cardioprotective effect by repressing cardiac myocyte apoptosis and myocardial fibrosis (17); eUb could mediate chemotaxis and modulate the phenotype and function of fibroblasts (18,19). eUb was also supposed to stimulate the proliferative ability of hepatectomized alcoholic liver cells in vivo (13). More importantly, Yan et al. verified that eUb might promote the acute lung infection-stimulated lung tumor metastasis (20); However, Job et al. confirmed that the eUb intravenous administration of up to 100 mg/kg did not display any toxic effects (21). These findings indicated the cell-type specific effects of eUb (22), and the effect of eUb would be influenced by the fundamental pathological state. The previous studies of our group have demonstrated that eUb could enhance the inhibiting effect of regulatory T cells on effector T cells (23) and stimulate Th2 cytokine IL-4 production while repressing Th1 cytokine IFN-γ (6). Meanwhile, we confirmed that eUb promoted lung tumor metastasis and reduced the long-term survival rate of melanoma mice (24). In this study however, we observed that eUb did not directly influence hepatoma cell proliferation and apoptosis. In view of the immunoregulatory effect of eUb, we speculated that eUb might modulate the function of immunocytes in the tumor microenvironment to influence the characteristics of hepatoma cells.

Recently, the transfusion of stored RBCs was demonstrated to exacerbate the sepsis-induced liver injury, which might be related to the activation of M1-polarized Kupffer cells (25). Therefore, the increased eUb in aged RBCs might modulate macrophage function to affect the progression and recurrence of HCC after stored RBC transfusion. From our results, the proliferation of hepatoma cells was not influenced while the Akt/mTOR signaling pathway in hepatoma cells was activated after co-culturing with the macrophages pretreated by eUb. In the meantime, the apoptosis of hepatoma cells was inhibited significantly after co-culturing. Since cancer development and progression rely on the tumor microenvironment, the cytokines released by macrophages after eUb treatment might provide a preferable microenvironment for the progression and recurrence of HCC.

Macrophages are soldiers of innate immunity and play an important role in tissue turnover, organ development, and regeneration (26,27). TAMs refer to the macrophages that infiltrate into tumor tissue and represent vital regulators of the complicated interaction between the immune system and cancer. Macrophages are plastic cells that can transform from one phenotype to another. Macrophages polarize toward “M1” (classically activated macrophages) or “M2” (alternatively activated macrophages) phenotype (28,29) in a manner dependent on their microenvironment. Induced by Th1 cytokines and microbial factors, M1 macrophages (M1s) secrete TNF-α, IL-12, and nitric oxide, promoting a pro-inflammatory response and mediating antimicrobial defense, and having an anti-tumor effect. While M2 macrophages (M2s) are induced by IL-13, IL-4 and glucocorticoids to secret arginase, TGF-β and IL-10, mediating inflammation resolution, angiogenesis, wound repair and tumor progression (28,30). In this study, we confirmed that eUb modulated the phenotype and secretion function of macrophages and eUb might enhance the carcinogenicity of hepatoma cells via the involvement of macrophages. Since eUb inhibited the concentration of TNF-α secreted by macrophages, we speculated that the extrinsic apoptosis signaling pathway of hepatoma cells might be affected after the co-culturing. Meanwhile, Bcl-xl abundance was increased which is a transmembrane molecule in the mitochondria and acts as an anti-apoptotic protein. Therefore, the intrinsic apoptosis pathway also could participate in the apoptosis initiated by the involvement of macrophages pretreated by eUb. However, ROS level, mitochondria membrane potential, the expression of cytochrome c and Apaf-1 should be detected to clarify the specific mechanism of Ub inhibiting cell apoptosis in the future study.

Conclusions

In this study, we demonstrated the pro-tumor potential of extracellular Ub in vitro. Act as a highly conserved protein in all eukaryotic cells, though eUb didn’t influence the proliferation and apoptosis of hepatoma cells directly, it still modulated the crucial biological properties of hepatoma cells by affecting the local microenvironment via the involvement of macrophages. However, our findings need to be demonstrated in vivo and further studies are needed to decipher the specific alterations of macrophages induced by eUb. In addition, we will use short- and long-time stored blood supernatant (with or without Ub depletion) to confirm the immunoregulation effect of eUb. The results of our study may provide some insights for removing the Ub released by aged RBCs to inhibit the progression and recurrence of HCC, thus improving the efficacy of aged RBCs transfusion for HCC patients.